Proxsys Rx Revenue and Competitors
Estimated Revenue & Valuation
- Proxsys Rx's estimated annual revenue is currently $20.7M per year.
- Proxsys Rx's estimated revenue per employee is $201,000
Employee Data
- Proxsys Rx has 103 Employees.
- Proxsys Rx grew their employee count by 24% last year.
Proxsys Rx's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Pharmacist | Reveal Email/Phone |
2 | Chief Pharmacist | Reveal Email/Phone |
3 | VP Human Resources | Reveal Email/Phone |
4 | VP, Integrations | Reveal Email/Phone |
5 | VP Growth | Reveal Email/Phone |
6 | VP Accounting | Reveal Email/Phone |
7 | Director Information Services and Technology | Reveal Email/Phone |
8 | Chief Strategy Officer | Reveal Email/Phone |
9 | Director, Facilities & Implementation | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Proxsys Rx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.9M | 94 | 4% | N/A | N/A |
#2 | $10.3M | 51 | -28% | N/A | N/A |
#3 | $44.8M | 223 | 7% | N/A | N/A |
#4 | $16.5M | 82 | -1% | N/A | N/A |
#5 | $26.7M | 133 | 4% | N/A | N/A |
#6 | $42M | 209 | -3% | N/A | N/A |
#7 | $1.4M | 14 | 8% | N/A | N/A |
#8 | $66.3M | 330 | -3% | N/A | N/A |
#9 | $13.9M | 69 | 1% | N/A | N/A |
#10 | $32.2M | 160 | -10% | N/A | N/A |
What Is Proxsys Rx?
Proxsys Rx is a healthcare solutions company that vertically integrates outpatient pharmacy into the continuum of care for health systems and their affiliated contracting agents. Proxsys Rx finances and operates local outpatient pharmacy operations, providing health care systems with long-term cost savings by reducing readmissions, improving HCAHPS scores, and improving other key health system strategic indicators that impact reimbursements and margins and accelerate Meaningful Use compliance. Key Benefits for Hospitals and Medical Centers : Bedside Rx delivery Reduced Readmissions Decreased employee medical expense Improved patient satisfaction scores Enhanced 340 B savings While 10 percent of healthcare costs are spent on prescriptions drugs, their ability to control the health status of patients and the cost of care is enormous. Emerging healthcare compensation initiatives (e.g. Shared Savings, Gain Sharing, etc.) are rapidly replacing traditional fee-for-service models. Hospitals and health systems are one of several categories that will be held accountable for the quality, cost, and care for specific groups of patients. An integrated outpatient pharmacy initiative can be a key contributor to guaranteeing health systems success by ensuring appropriateness of medication use, reducing medication-related adverse events, preventing hospital readmissions, helping patients manage chronic conditions and much more.
keywords:N/AN/A
Total Funding
103
Number of Employees
$20.7M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Proxsys Rx News
Proxsys Rx, partnering with John C. Stennis Memorial Hospital, is opening a community pharmacy in DeKalb by mid-December.
Proxsys Rx, partnering with John C. Stennis Memorial Hospital, is opening a community pharmacy in DeKalb by mid-December.
Proxsys Rx, partnering with John C. Stennis Memorial Hospital, is opening a community pharmacy in DeKalb by mid-December.
ProxsysRX and Talon collaborate to offer outpatient follow-up solution ProxsysRx is forming a strategic partnership with Talon Health Data Solutions to reduce unnecessary hospital readmissions and improve patient satisfaction scores (HCAHPS) through their comprehensive omnichannel communication ...
ProxsysRx, a Birmingham, Ala.-based healthcare solutions company, received a growth equity investment from Atlanta-based Fulcrum Equity Partners with participation from members of the management team. The amount of the deal was not disclosed. Fulcrum Partners Tom Greer and Jeff Muir lead the fu ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.3M | 103 | 11% | N/A |
#2 | $29.9M | 103 | -6% | N/A |
#3 | $33.1M | 103 | -59% | N/A |
#4 | $35M | 104 | 3% | N/A |
#5 | $12.5M | 104 | 3% | N/A |